These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 35092938)

  • 1. Generation of homozygous Na
    Maurer W; Hartmann N; Argyriou L; Sossalla S; Streckfuss-Bömeke K
    Stem Cell Res; 2022 Apr; 60():102677. PubMed ID: 35092938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determining the Pathogenicity of a Genomic Variant of Uncertain Significance Using CRISPR/Cas9 and Human-Induced Pluripotent Stem Cells.
    Ma N; Zhang JZ; Itzhaki I; Zhang SL; Chen H; Haddad F; Kitani T; Wilson KD; Tian L; Shrestha R; Wu H; Lam CK; Sayed N; Wu JC
    Circulation; 2018 Dec; 138(23):2666-2681. PubMed ID: 29914921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of heterozygous (MRli003-A-5) and homozygous (MRli003-A-6) voltage-sensing knock-in human iPSC lines by CRISPR/Cas9 editing of the AAVS1 locus.
    Zhang F; Meier AB; Sinnecker D; Engelhardt S; Lipp P; Laugwitz KL; Dorn T; Moretti A
    Stem Cell Res; 2022 May; 61():102785. PubMed ID: 35421847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Na
    Pierre M; Djemai M; Poulin H; Chahine M
    Sci Rep; 2021 Aug; 11(1):17168. PubMed ID: 34433864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A simple, quick, and efficient CRISPR/Cas9 genome editing method for human induced pluripotent stem cells.
    Geng BC; Choi KH; Wang SZ; Chen P; Pan XD; Dong NG; Ko JK; Zhu H
    Acta Pharmacol Sin; 2020 Nov; 41(11):1427-1432. PubMed ID: 32555510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homozygous might be hemizygous: CRISPR/Cas9 editing in iPSCs results in detrimental on-target defects that escape standard quality controls.
    Simkin D; Papakis V; Bustos BI; Ambrosi CM; Ryan SJ; Baru V; Williams LA; Dempsey GT; McManus OB; Landers JE; Lubbe SJ; George AL; Kiskinis E
    Stem Cell Reports; 2022 Apr; 17(4):993-1008. PubMed ID: 35276091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of a human induced pluripotent stem cell line JHUi003-A with homozygous mutation for spinocerebellar ataxia type 12 using genome editing.
    Feng H; Li Q; Margolis RL; Li PP
    Stem Cell Res; 2021 May; 53():102346. PubMed ID: 34087983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular and Functional Relevance of Na
    Hartmann N; Knierim M; Maurer W; Dybkova N; Hasenfuß G; Sossalla S; Streckfuss-Bömeke K
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of a CRISPR/Cas9-edited Plakoglobin (JUP) knock-out (JMUi001-A-4) iPSC line to model the cardiac phenotype of arrhythmogenic cardiomyopathy.
    Walz K; Janz A; Klopocki E; Gerull B
    Stem Cell Res; 2023 Dec; 73():103240. PubMed ID: 37995437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Na
    Hartmann N; Knierim M; Maurer W; Dybkova N; Zeman F; Hasenfuß G; Sossalla S; Streckfuss-Bömeke K
    Int J Mol Sci; 2024 Jun; 25(11):. PubMed ID: 38892333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of a homozygous CRISPR/Cas9-mediated knockout human iPSC line for PTCH1 gene.
    Zu B; Zhang X; You G; Fu Q
    Stem Cell Res; 2021 Oct; 56():102517. PubMed ID: 34509918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of the CRISPR/Cas9-mediated KIF1C knock-out human iPSC line HIHRSi003-A-1.
    Nagel M; Müßig S; Höflinger P; Schöls L; Hauser S; Schüle R
    Stem Cell Res; 2020 Dec; 49():102059. PubMed ID: 33161238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trichostatin A for Efficient CRISPR-Cas9 Gene Editing of Human Pluripotent Stem Cells.
    Molugu K; Khajanchi N; Lazzarotto CR; Tsai SQ; Saha K
    CRISPR J; 2023 Oct; 6(5):473-485. PubMed ID: 37676985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of two PITX2 knock-out human induced pluripotent stem cell lines using CRISPR/Cas9 system.
    Mun D; Kang JY; Chun Y; Park DS; Kim H; Yun N; Lee SH; Joung B
    Stem Cell Res; 2022 Dec; 65():102940. PubMed ID: 36260954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR/Cas9-edited PKP2 knock-out (JMUi001-A-2) and DSG2 knock-out (JMUi001-A-3) iPSC lines as an isogenic human model system for arrhythmogenic cardiomyopathy (ACM).
    Janz A; Zink M; Cirnu A; Hartleb A; Albrecht C; Rost S; Klopocki E; Günther K; Edenhofer F; Ergün S; Gerull B
    Stem Cell Res; 2021 May; 53():102256. PubMed ID: 33640690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of heterozygous (MRli003-A-3) and homozygous (MRli003-A-4) TRPM4 knockout human iPSC lines.
    Zhang F; Meier AB; Lipp P; Laugwitz KL; Dorn T; Moretti A
    Stem Cell Res; 2022 Apr; 60():102731. PubMed ID: 35245852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome Editing of Induced Pluripotent Stem Cells Using CRISPR/Cas9 Ribonucleoprotein Complexes to Model Genetic Ocular Diseases.
    Getachew H; Chinchilla B; Fernandez-Godino R
    Methods Mol Biol; 2022; 2549():321-334. PubMed ID: 34128206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR/Cas9 Genome Editing of Human-Induced Pluripotent Stem Cells Followed by Granulocytic Differentiation.
    Dannenmann B; Nasri M; Welte K; Skokowa J
    Methods Mol Biol; 2020; 2115():471-483. PubMed ID: 32006418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of a homozygous ABCA7-knockout human iPSC line using the CRISPR/Cas9 system.
    Guan M; Chai Y; Yi R; Chen Y; Ip JPK; Ye T; Chen Y
    Stem Cell Res; 2023 Feb; 66():103000. PubMed ID: 36521383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR/Cas9-Mediated Genome Editing to Generate Clonal iPSC Lines.
    Sanjurjo-Soriano C; Erkilic N; Mamaeva D; Kalatzis V
    Methods Mol Biol; 2022; 2454():589-606. PubMed ID: 33755901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.